| http://dbpedia.org/ontology/abstract
|
Zealand Pharma A/S is a Danish biotechnolo … Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018 they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.edish life science cluster Medicon Valley.
|
| http://dbpedia.org/ontology/foundingYear
|
1998
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Martin_Nicklasson +
, http://dbpedia.org/resource/Dr._Adam_Steensberg +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
200
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Lyxumia +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://zealandpharma.com/product-pipeline +
, https://www.zealandpharma.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
62793631
|
| http://dbpedia.org/ontology/wikiPageLength
|
8013
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1118535559
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Lyxumia +
, http://dbpedia.org/resource/Medicon_Valley +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Denmark +
, http://dbpedia.org/resource/Sanofi +
, http://dbpedia.org/resource/Pharmaceutical_companies +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Tissue_%28biology%29 +
, http://dbpedia.org/resource/Angioplasty +
, http://dbpedia.org/resource/Obesity +
, http://dbpedia.org/resource/Martin_Nicklasson +
, http://dbpedia.org/resource/Copenhagen +
, http://dbpedia.org/resource/Dr._Adam_Steensberg +
, http://dbpedia.org/resource/Diabetes +
, http://dbpedia.org/resource/Danish_krone +
, http://dbpedia.org/resource/Copenhagen_Stock_Exchange +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Anti-diabetic_medication +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Pound_sterling +
, http://dbpedia.org/resource/S%C3%B8borg +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Stock_exchange +
, http://dbpedia.org/resource/Gastrointestinal_tract +
, http://dbpedia.org/resource/Rigshospitalet +
, http://dbpedia.org/resource/Preclinical_development +
, http://dbpedia.org/resource/Metabolic_diseases +
|
| http://dbpedia.org/property/equity
|
14
|
| http://dbpedia.org/property/equityYear
|
2019
|
| http://dbpedia.org/property/founded
|
1998
|
| http://dbpedia.org/property/homepage
|
https://www.zealandpharma.com/ +
|
| http://dbpedia.org/property/hqLocation
|
Sydmarken 11, 2860 Søborg, Denmark
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Martin_Nicklasson +
, http://dbpedia.org/resource/Dr._Adam_Steensberg +
|
| http://dbpedia.org/property/name
|
Zealand Pharma
|
| http://dbpedia.org/property/numEmployees
|
About 200
|
| http://dbpedia.org/property/products
|
Lyxumia
, Danegaoptide
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Denmark +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Zealand_Pharma?oldid=1118535559&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.zealandpharma.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Zealand_Pharma +
|
| http://xmlns.com/foaf/0.1/name
|
Zealand Pharma
|
| owl:sameAs |
http://dbpedia.org/resource/Zealand_Pharma +
, http://da.dbpedia.org/resource/Zealand_Pharma +
, https://global.dbpedia.org/id/neBn +
, http://www.wikidata.org/entity/Q18552286 +
|
| rdf:type |
http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
Zealand Pharma A/S is a Danish biotechnolo … Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018 they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.edish life science cluster Medicon Valley.
|
| rdfs:label |
Zealand Pharma
|
